Coeptis Pharmaceuticals, Inc. is a privately held biopharmaceutical company engaged in the acquisition, development and commercialization of branded pharmaceutical products. Headquartered near Pittsburgh, PA, Coeptis Pharmaceuticals holds a expansive portfolio of 505(b)(2) assets in various stages of development and commercialization.
Our emphasis are products that present unique opportunities for the healthcare community. We work across all therapeutic areas to identify, develop, and commercialize products that are marketed to retail and non-retail prescription drug channels.